Why are intramuscular (but not intravenous) injections of rhig contraindicated in thrombocytopenic patients?

Hematoma. Intramuscular injections in a thrombocytopenic patient would result in bleeding in the muscle and create a hematoma. The same risk is not there with an intravenous injection.